Quipt Home Medical Corp. — Cyborg Score 4/10

Mixed
Home Medical Equipment (HME) and Respiratory Care Services

Strategic Profile

The company maintains strategic relationships with integrated health systems through a 60% ownership interest in Hart Medical Equipment, embedding operations into hospital discharge processes across more than 19 hospitals and affiliated care facilities. The company has recently announced a 50% stock drop in 2025, though its recurring revenue model and strong gross margins provide stability.

Cyborg Score Rationale

The company has a negative EPS of -0.2400 TTM with no clear profitability path. However, the acquisition announcement at a significant premium suggests underlying value recognition by experienced capital providers. Recent shareholder litigation concerns and operational challenges offset potential recurring revenue strengths.

Top Insights

  • In December 2025, Quipt entered a definitive agreement for acquisition by affiliates of Kingswood Capital Management and Forager Capital Management at US$3.65 per share in an all-cash transaction.
  • The acquisition price represents a 162% premium to the company's unaffected stock price on May 19, 2025.
  • The company's expertise spans end-to-end respiratory care solutions, including technology-enabled equipment for patients with cardio and pulmonary diseases, sleep disorders, and mobility challenges.
  • The company is headquartered in Wilder, Kentucky.

Named Competitors

  • Medical Equipment Distribution — Large-scale pharmaceutical and medical equipment distributor
  • Medical Equipment Distribution — Global healthcare services and products company
  • Neuromodulation & Respiratory Equipment — Medical device and respiratory equipment provider

Recent Developments

  • (December 2025) Definitive acquisition agreement with Kingswood Capital and Forager Capital at $3.65/share
  • (July 2025) Transaction adding $60 million in revenue and 29 locations, marking entry into Michigan market
  • (February 2025) Q1 results with focus on optimizing capital allocation and expanding de novo locations

Open the full interactive Quipt Home Medical Corp. report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.

Open report →